The American scientists from Mount Sinai Hospital, New York, determined those blood thinners may help in the treatment of patients with severe mode of Covid-19 as CNN reported.
“Our findings suggest that systemic anticoagulants may be associated with improved outcomes among patients hospitalized with Covid-19,” the report, published in the Journal of the American College of Cardiology says.
Particularly, the issue is about the solution of blood clots throughout the body of people infected with the coronavirus. Dr. Valentin Fuster and his colleagues examined over 2,700 patients treated at Mount Sinai Hospital. Since March, the patients received anti-clotting drugs.
The medics found out that among patients, who received such drugs, 29% died, while 63% died among patients who did not receive them.
“The patients who received anticoagulants did better than those who didn’t,” Fuster told.
The scientists noted that the findings are not clear enough to provide recommendations for the treatment of patients.
Earlier, medics from the British Centre for Perioperative Care stated that the terms of the health restoration after coronavirus may last from one week up to a year.